SEC Info - American Renal Associates Holdings, Inc. - ‘10-K’ for 12/31/19

American Renal Associates Holdings, Inc. – ‘10-K’ for 12/31/19 – ‘EX-32.1’

On: Monday, 3/16/20, at 4:07pm ET · For: 12/31/19 · Accession #: 1498068-20-37 · File #: 1-37751

Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 2.47M 2: EX-21.1 Subsidiaries List HTML 96K 3: EX-23.1 Consent of Experts or Counsel HTML 30K 4: EX-31.1 Certification -- §302 - SOA'02 HTML 37K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 37K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 32K 7: EX-32.2 Certification -- §906 - SOA'02 HTML 32K 53: R1 Cover Page HTML 95K 99: R2 Consolidated Balance Sheets HTML 148K 84: R3 Consolidated Balance Sheets (Parenthetical) HTML 50K 18: R4 Consolidated Statements of Operations HTML 113K 52: R5 Consolidated Statements of Comprehensive Loss HTML 52K 97: R6 Consolidated Statements of Changes in Equity HTML 132K 82: R7 Consolidated Statements of Cash Flows HTML 157K 14: R8 Basis of Presentation and Organization HTML 36K 55: R9 Summary of Significant Accounting Policies HTML 124K 103: R10 Cash HTML 40K 66: R11 Prepaid Expenses and Other Current Assets HTML 38K 29: R12 Acquisitions and Divestitures HTML 66K 43: R13 Fair Value Measurements HTML 115K 104: R14 Property and Equipment HTML 50K 67: R15 Intangible Assets and Goodwill HTML 57K 30: R16 Assets Held for Sale HTML 56K 44: R17 Accrued Expenses and Other Current Liabilities HTML 48K 105: R18 Variable Interest Entities HTML 38K 65: R19 Noncontrolling Interests Subject to Put Provisions HTML 61K 23: R20 Changes in Ownership Interest in Consolidated HTML 47K Subsidiaries 62: R21 Debt HTML 95K 101: R22 Leases HTML 226K 89: R23 Income Taxes HTML 124K 24: R24 Loss Per Share HTML 53K 63: R25 Stock-Based Compensation HTML 122K 102: R26 Related Party Transactions HTML 54K 90: R27 Commitments and Contingencies HTML 38K 22: R28 Certain Legal Matters and Other Matters HTML 60K 64: R29 Employee Benefit Plan HTML 33K 42: R30 Concentrations HTML 34K 27: R31 Subsequent Events HTML 32K 69: R32 Selected Quarterly Financial Data (Unaudited) HTML 78K 107: R33 Schedule Ii - Valuation and Qualifying Accounts HTML 48K 41: R34 Summary of Significant Accounting Policies HTML 161K (Policies) 26: R35 Summary of Significant Accounting Policies HTML 47K (Tables) 68: R36 Cash (Tables) HTML 49K 106: R37 Prepaid Expenses and Other Current Assets (Tables) HTML 39K 39: R38 Acquisitions and Divestitures (Tables) HTML 47K 28: R39 Fair Value Measurements (Tables) HTML 108K 61: R40 Property and Equipment (Tables) HTML 45K 20: R41 Intangible Assets and Goodwill (Tables) HTML 61K 80: R42 Assets Held for Sale (Tables) HTML 56K 92: R43 Accrued Expenses and Other Current Liabilities HTML 49K (Tables) 60: R44 Noncontrolling Interests Subject to Put Provisions HTML 55K (Tables) 19: R45 Changes in Ownership Interest in Consolidated HTML 48K Subsidiaries (Tables) 79: R46 Debt (Tables) HTML 64K 91: R47 Leases (Tables) HTML 126K 59: R48 Income Taxes (Tables) HTML 125K 21: R49 Loss Per Share (Tables) HTML 52K 37: R50 Stock-Based Compensation (Tables) HTML 101K 49: R51 Selected Quarterly Financial Data (Unaudited) HTML 78K (Tables) 108: R52 Basis of Presentation and Organization (Details) HTML 45K 70: R53 Summary of Significant Accounting Policies HTML 165K (Details) 38: R54 Summary of Significant Accounting Policies HTML 44K Schedule of Revenue (Details) 50: R55 Cash (Details) HTML 41K 109: R56 Prepaid Expenses and Other Current Assets HTML 38K (Details) 71: R57 Acquisitions and Divestitures - Acquisitions HTML 65K (Details) 35: R58 Acquisitions and Divestitures - Divestitures HTML 77K (Details) 51: R59 Fair Value Measurements - Narrative (Details) HTML 37K 93: R60 Fair Value Measurements - Schedule of fair value HTML 86K (Details) 85: R61 Fair Value Measurements - Fair value rollforward HTML 40K of tax receivable agreement liability (Details) 13: R62 Property and Equipment (Details) HTML 76K 54: R63 Intangible Assets and Goodwill - Schedule of HTML 56K intangible assets (Details) 96: R64 Intangible Assets and Goodwill - Estimated annual HTML 47K amortization expense (Details) 88: R65 Intangible Assets and Goodwill - Changes in the HTML 40K value of goodwill (Details) 17: R66 Assets Held for Sale - Narrative (Details) HTML 80K 58: R67 Assets Held for Sale - Schedule of assets and HTML 75K liabilities held for sale (Details) 98: R68 Accrued Expenses and Other Current Liabilities HTML 54K (Details) 83: R69 Variable Interest Entities (Details) HTML 34K 75: R70 Noncontrolling Interests Subject to Put Provisions HTML 66K (Details) 115: R71 Changes in Ownership Interest in Consolidated HTML 48K Subsidiaries (Details) 48: R72 Debt - Schedule of long term-term debt (Details) HTML 73K 34: R73 Debt Debt - Scheduled maturities of long-term debt HTML 51K (Details) 72: R74 Debt - Narrative (Details) HTML 150K 112: R75 Leases - Narrative (Details) HTML 59K 45: R76 Lease Cost (Details) HTML 47K 31: R77 Leases - Supplemental Cash Flow Related to Leases HTML 44K (Details) 77: R78 Leases - Supplemental Balance Sheet Related to HTML 66K Leases (Details) 111: R79 Leases - Future Minimum Lease Payments Under HTML 106K Noncancelable Leases - After ASU 2016-02 (Details) 74: R80 Leases - Future Minimum Lease Payments Under HTML 117K Noncancelable Leases - Before ASU 2016-02 (Details) 114: R81 Income Taxes - Provision (Benefit) for Income HTML 52K Taxes (Details) 47: R82 Income Taxes - Significant components of deferred HTML 78K tax assets and liabilities (Details) 33: R83 Income Taxes - Narrative (Details) HTML 60K 73: R84 Income Taxes - Reconciliation of the federal HTML 57K statutory rate (Details) 113: R85 Income Taxes - Gross amounts of unrecognized tax HTML 38K benefits (Details) 46: R86 Loss Per Share (Details) HTML 56K 32: R87 Stock-Based Compensation - Narrative (Details) HTML 135K 76: R88 Stock-Based Compensation - Equity Grants, HTML 41K Assumptions and Activity (Details) 110: R89 Stock-Based Compensation - Assumptions used for HTML 51K options granted (Details) 94: R90 Stock-Based Compensation - Stock option activity HTML 85K (Details) 86: R91 Stock-Based Compensation - Restricted stock HTML 56K activity (Details) 15: R92 Related Party Transactions (Details) HTML 119K 56: R93 Commitments and Contingencies (Details) HTML 42K 95: R94 Certain Legal Matters and Other Matters (Details) HTML 64K 87: R95 Employee Benefit Plan (Details) HTML 32K 16: R96 Concentrations (Details) HTML 31K 57: R97 Selected Quarterly Financial Data (Unaudited) HTML 59K (Details) 100: R98 Schedule Ii - Valuation and Qualifying Accounts HTML 38K (Details) 40: XML IDEA XML File -- Filing Summary XML 212K 81: XML XBRL Instance -- ara1231201910-kxdocume_htm XML 3.11M 36: EXCEL IDEA Workbook of Financial Reports XLSX 139K 9: EX-101.CAL XBRL Calculations -- ara-20191231_cal XML 460K 10: EX-101.DEF XBRL Definitions -- ara-20191231_def XML 867K 11: EX-101.LAB XBRL Labels -- ara-20191231_lab XML 2.79M 12: EX-101.PRE XBRL Presentations -- ara-20191231_pre XML 1.58M 8: EX-101.SCH XBRL Schema -- ara-20191231 XSD 267K 25: JSON XBRL Instance as JSON Data -- MetaLinks 568± 868K 78: ZIP XBRL Zipped Folder -- 0001498068-20-000037-xbrl Zip 678K

Exhibit 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of American Renal Associates Holdings, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Joseph A. Carlucci, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Joseph A. Carlucci

Joseph A. Carlucci

Chief Executive Officer

Date: March 16, 2020

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

This ‘10-K’ Filing

Date

Other Filings

Filed on:

3/16/20

8-K

For Period end:

12/31/19

List all Filings

As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/15/20 American Renal Assocs Holdin… Inc DEFM14A 12/15/20 1:3.7M Broadridge Fin’l So… Inc 11/24/20 American Renal Assocs Holdin… Inc PREM14A 11/24/20 1:3.7M Broadridge Fin’l So… Inc

American Renal Associates Holdings, Inc. – ‘10-K’ for 12/31/19 – ‘EX-32.1’

On: Monday, 3/16/20, at 4:07pm ET · For: 12/31/19 · Accession #: 1498068-20-37 · File #: 1-37751

Previous ‘10-K’: ‘10-K’ on 9/5/19 for 12/31/18 · Latest ‘10-K’: This Filing · 2 References:

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

‘EX-32.1’ — Certification — §906 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

2 Subsequent Filings that Reference this Filing

American Renal Associates Holdings, Inc. – ‘10-K’ for 12/31/19 – ‘EX-32.1’

On: Monday, 3/16/20, at 4:07pm ET · For: 12/31/19 · Accession #: 1498068-20-37 · File #: 1-37751

Previous ‘10-K’: ‘10-K’ on 9/5/19 for 12/31/18 · Latest ‘10-K’: This Filing · 2 References: By: American Renal Associates Holdings, Inc. – ‘DEFM14A’ on 12/15/20 By: American Renal Associates Holdings, Inc. – ‘PREM14A’ on / for 11/24/20

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘EX-32.1’ — Certification — §906 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

2 Subsequent Filings that Reference this Filing

Previous ‘10-K’: ‘10-K’ on 9/5/19 for 12/31/18 · Latest ‘10-K’: This Filing · 2 References:

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents